Torrent Pharma Completes Amalgamation of J. B. Chemicals; Capital Restructure Announced
Torrent Pharmaceuticals Limited has announced that the Scheme of Amalgamation involving J. B. Chemicals & Pharmaceuticals Limited has become effective, following its approval and sanction by the National Company Law Tribunal (NCLT). The completed merger marks a significant step in the company’s corporate structure.The scheme involves the amalgamation of J. B. Chemicals ('Transferor Company') with Torrent Pharmaceuticals Limited ('Torrent Pharma'). This integration was sanctioned by the Hon'ble NCLT, Ahmedabad Bench, vide its order dated July 6, 2026. The certified copy of this order was received on July 7, 2026.
The amalgamation became effective on July 8, 2026, after Torrent Pharma and J B Chemicals submitted the certified copies of the Order and the Scheme to the Registrar of Companies in Ahmedabad. As a result of the scheme's effectiveness, J B Chemicals stands amalgamated into and with Torrent Pharma, dissolving without being wound up. The Appointed Date for this amalgamation was January 21, 2026.
In accordance with the completion of the scheme, the capital clause of the Memorandum of Association of Torrent Pharmaceuticals Limited has been amended. The total capital of the company stands at ₹ 2,55,30,00,000/- (Rupees Two Hundred Fifty Five Crores Thirty Lakhs).
The updated shareholding structure is detailed below:
| Share Type | Total Number of Shares | Face Value |
|---|---|---|
| Equity Shares | 46,06,00,000 | ₹ 5/- each |
| Preference Shares | 25,00,000 | ₹ 100/- each |
The company retains the power to increase and reduce its capital, divide shares into various classes, and vary or modify any existing rights or privileges as per its Articles of Association.
TORNTPHARM Stock Price Movement
As of 10:20 AM, shares of Torrent Pharmaceuticals Limited are edging higher, trading at ₹4897.8 after gaining 0.85% in live trading today. The stock maintains strong momentum as it approaches its all-time high mark of ₹4913, with a total traded volume reported at 156,506 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.